1[1]Kleiner DE,Stetler-stevenson WG.Matrix metalloproteinase and metastasis [J].Cancer Chemother Pharmaco1.1999,43(Supp1):s42～51
2[2]Mauviel A.Cytokine regulation of metalloproteinase gene expression. J Cell Biochem,1993,53:288～295
3[3]Karin M,Liu Z,Zandi E.AP-1 function and regulation.Curr Opin Cell Biol,1997,9:240～246
4[4]Westermarck J,Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion.FASEB J,1999,13(8):781～792
5[5]Kurata H,Thant AA,Matsuo S, et al.Constitutive activation of MAP kinase (MEK1) is critical and sufficient for the activation of MMP-2 [J] Exp Cell Res,2000,254(1):180～188
6[6]Bescond A,Augier T,Charegre C,et al,Influence of homocysteine on matrix metalloproteinase-2:activation and activity.Biochem Biophys Res Commun,1999,263(2):498～503
7[7]Itoh Y,Ito A,Iwata K,et al.Plasma membrane-bound tissue inhibitor of metalloproteinase 2 (TIMP-2) specifically inhibit matrix metalloproteinase 2 (gelatinase A) activated on the cell surface [J]. J Biol chem,1998,273(38):24360～24367
8[8]Greene J,Wang M,Liu Y E,et al.Molecular cloning and characterization of human tissue inhibitor of metalloproteinases 4.J Biol Chem,1996,271:30375～30380
9[9]Bode W,Fernandez Catalan C,Grams F,et al.Insights into MMP-TIMP interactions [J].Ann N Y Acad Sci,1999,878:73～91
10[10]Fillmore HL,VanMeter TE,Broaddus WC. Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion. J Neurooncol,2001,53(2):187～202
同被引文献7
1Orr-Weaver TL. Perspectives: cell cycle. The difficulty in sepa- rating sisters[J].Science, 1999,285 344-345.
2Zhang X, Horwitz GA, Prezant TR, et al. Structure, expres- sion, and functionof human pituitary tumor-transforming gene (PTTG) [J]. Mol Endocrinol, 1999,13 (1) 156-166.
3Nouyuki Genkai, Jumpei Homma, Masakazu Sano. Increased expression of pituitary tumor-transforming gene (PTTG)-I is correlated with poor prognosis in glioma patients[J].J Oneol ReD,2006,15(6),1569-1574.
4Chamanon K, Kirches E, Kanakis D, et al. Regulation of the pi- tuitary tumor transforming gene by insulin-like-growth factor- I and insulin differs between malignant and non-neoplastic as- trocytes[J]. Biochem Biophys Res Commun, 2005,27,331 ( 1 ) 86-92.
5Tfelt-Hansen J, Yano S, Bandyopadhyay S, et al. Expression of pitu- itary tumor transforming gene (PTTG) and its binding protein in human astrocytes and astrocytoma cells: function and regulation of PTTG in U87 astrocytoma cclls[J]. Endocrinology,2004,145 (9) 4 222-4 231.
6Hur JH, Park MJ, Park IC, et al. Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP 2) may be correlated with membrane type-1 matrix metalloproteinase (MT1-MMP) expression[J].J Korean Med Sci,2000,15(3) :309-314.
7Mohammad TM, Sham SK. Regulation of angiogenesis and in- vasion by human pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metallo- proteinase-2 (MMP-2) [J]. Mol Cancer, 2006,5 61.
